
Dennis H. Pedder
Examiner (ID: 14040, Phone: (571)272-6667 , Office: P/3612 )
| Most Active Art Unit | 3612 |
| Art Unit(s) | 2899, 3102, 3106, 3612, 3642 |
| Total Applications | 5987 |
| Issued Applications | 4919 |
| Pending Applications | 211 |
| Abandoned Applications | 929 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11684093
[patent_doc_number] => 09682125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Compositions and methods for treating cognitive deficits'
[patent_app_type] => utility
[patent_app_number] => 14/853707
[patent_app_country] => US
[patent_app_date] => 2015-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 16305
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853707
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/853707 | Compositions and methods for treating cognitive deficits | Sep 13, 2015 | Issued |
Array
(
[id] => 11969763
[patent_doc_number] => 20170273917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'NMDA RECEPTOR ANTAGONISTS FOR TREATING GAUCHER DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/511033
[patent_app_country] => US
[patent_app_date] => 2015-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25902
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511033
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/511033 | NMDA RECEPTOR ANTAGONISTS FOR TREATING GAUCHER DISEASE | Sep 9, 2015 | Abandoned |
Array
(
[id] => 11031493
[patent_doc_number] => 20160228449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'METHODS OF TREATING PRADER WILLI SYNDROME AND CONDITIONS ASSOCIATED WITH LOW BASAL METABOLIC RATE OR HYPERPHAGIA USING A KATP CHANNEL OPENER'
[patent_app_type] => utility
[patent_app_number] => 14/849679
[patent_app_country] => US
[patent_app_date] => 2015-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9864
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14849679
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/849679 | METHODS OF TREATING PRADER WILLI SYNDROME AND CONDITIONS ASSOCIATED WITH LOW BASAL METABOLIC RATE OR HYPERPHAGIA USING A KATP CHANNEL OPENER | Sep 9, 2015 | Abandoned |
Array
(
[id] => 11992460
[patent_doc_number] => 20170296616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'METHODS OF TREATING DEPRESSION USING NMDA MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/503840
[patent_app_country] => US
[patent_app_date] => 2015-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8795
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503840 | METHODS OF TREATING DEPRESSION USING NMDA MODULATORS | Aug 12, 2015 | Abandoned |
| 14/821555 | DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS | Aug 6, 2015 | Abandoned |
Array
(
[id] => 11672719
[patent_doc_number] => 20170161441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'METHODS AND MATERIALS FOR TREATING PAIN AND DEPRESSION'
[patent_app_type] => utility
[patent_app_number] => 15/323708
[patent_app_country] => US
[patent_app_date] => 2015-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 20210
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15323708
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/323708 | METHODS AND MATERIALS FOR TREATING PAIN AND DEPRESSION | Jul 1, 2015 | Abandoned |
Array
(
[id] => 10815338
[patent_doc_number] => 20160161498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'DIAGNOSTIC METHOD FOR PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME (PANS) AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCI INFECTION (PANDAS)'
[patent_app_type] => utility
[patent_app_number] => 14/790416
[patent_app_country] => US
[patent_app_date] => 2015-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13598
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14790416
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/790416 | DIAGNOSTIC METHOD FOR PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME (PANS) AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCI INFECTION (PANDAS) | Jul 1, 2015 | Abandoned |
Array
(
[id] => 11628774
[patent_doc_number] => 20170138964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'Systems, Assays, and Methods for Determining Risk Factors for Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 15/323718
[patent_app_country] => US
[patent_app_date] => 2015-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11671
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15323718
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/323718 | Systems, assays, and methods for determining risk factors for Alzheimer's disease | Jun 30, 2015 | Issued |
Array
(
[id] => 10485946
[patent_doc_number] => 20150370965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'MULTIPLE BIOMARKER PANELS TO STRATIFY DISEASE SEVERITY AND MONITOR TREATMENT OF DEPRESSION'
[patent_app_type] => utility
[patent_app_number] => 14/746379
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 20712
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14746379
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/746379 | MULTIPLE BIOMARKER PANELS TO STRATIFY DISEASE SEVERITY AND MONITOR TREATMENT OF DEPRESSION | Jun 21, 2015 | Abandoned |
Array
(
[id] => 10665070
[patent_doc_number] => 20160011214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS'
[patent_app_type] => utility
[patent_app_number] => 14/742919
[patent_app_country] => US
[patent_app_date] => 2015-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 14349
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14742919
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/742919 | QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS | Jun 17, 2015 | Abandoned |
Array
(
[id] => 12924526
[patent_doc_number] => 09827220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-28
[patent_title] => Treatment for ischemic stroke
[patent_app_type] => utility
[patent_app_number] => 14/731783
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4224
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14731783
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/731783 | Treatment for ischemic stroke | Jun 4, 2015 | Issued |
Array
(
[id] => 10444593
[patent_doc_number] => 20150329608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/730396
[patent_app_country] => US
[patent_app_date] => 2015-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12003
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14730396
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/730396 | OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT | Jun 3, 2015 | Pending |
Array
(
[id] => 10380671
[patent_doc_number] => 20150265678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'METHODS OF TREATING COGNITIVE IMPAIRMENT'
[patent_app_type] => utility
[patent_app_number] => 14/730485
[patent_app_country] => US
[patent_app_date] => 2015-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 20943
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14730485
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/730485 | Methods of treating cognitive impairment | Jun 3, 2015 | Issued |
Array
(
[id] => 10380671
[patent_doc_number] => 20150265678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'METHODS OF TREATING COGNITIVE IMPAIRMENT'
[patent_app_type] => utility
[patent_app_number] => 14/730485
[patent_app_country] => US
[patent_app_date] => 2015-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 20943
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14730485
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/730485 | Methods of treating cognitive impairment | Jun 3, 2015 | Issued |
Array
(
[id] => 11937890
[patent_doc_number] => 20170242040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'METHOD FOR THE DIAGNOSIS OF ALZHEIMER\'S DISEASE AND MILD COGNITIVE IMPAIRMENT'
[patent_app_type] => utility
[patent_app_number] => 15/315078
[patent_app_country] => US
[patent_app_date] => 2015-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 24077
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315078
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/315078 | METHOD FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT | May 31, 2015 | Abandoned |
Array
(
[id] => 16184714
[patent_doc_number] => 10718021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-21
[patent_title] => Genetic markers for memory loss
[patent_app_type] => utility
[patent_app_number] => 15/312856
[patent_app_country] => US
[patent_app_date] => 2015-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7902
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312856
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/312856 | Genetic markers for memory loss | May 27, 2015 | Issued |
Array
(
[id] => 16565224
[patent_doc_number] => 10890589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Metabolic biomarkers for memory loss
[patent_app_type] => utility
[patent_app_number] => 15/313163
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7997
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313163
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313163 | Metabolic biomarkers for memory loss | May 26, 2015 | Issued |
Array
(
[id] => 11716113
[patent_doc_number] => 20170184613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'EXOSOME AND LIPID BIOMARKERS FOR MEMORY LOSS'
[patent_app_type] => utility
[patent_app_number] => 15/312804
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16402
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312804
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/312804 | EXOSOME AND LIPID BIOMARKERS FOR MEMORY LOSS | May 25, 2015 | Abandoned |
Array
(
[id] => 11677161
[patent_doc_number] => 09675669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Therapeutic use of a growth factor, METRNL'
[patent_app_type] => utility
[patent_app_number] => 14/721165
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 33651
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14721165
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/721165 | Therapeutic use of a growth factor, METRNL | May 25, 2015 | Issued |
Array
(
[id] => 11728024
[patent_doc_number] => 20170189467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCEMENT OF ABILITY TO CONCENTRATE'
[patent_app_type] => utility
[patent_app_number] => 15/312882
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5771
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312882
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/312882 | Methods and compositions for enhancement of ability to concentrate | May 21, 2015 | Issued |